European Heart Journal
Author:
Keywords:
Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, Guidelines, Pulmonary hypertension, Pulmonary arterial hypertension, Chronic thrombo-embolic pulmonary hypertension, Left heart disease, Congenital heart disease, Lung disease, Connective tissue disease, Endothelin receptor antagonists, Phosphodiesterase type 5 inhibitors, Soluble guanylate cyclase stimulators, Prostacyclin analogues, Prostacyclin receptor agonists, Pulmonary endarterectomy, Balloon pulmonary angioplasty, Lung transplantation, QUALITY-OF-LIFE, PRESERVED EJECTION FRACTION, ENDOTHELIN-RECEPTOR ANTAGONIST, CONTINUOUS INTRAVENOUS EPOPROSTENOL, CALCIUM-CHANNEL BLOCKERS, LONG-TERM OUTCOMES, RIGHT-VENTRICULAR DYSFUNCTION, EOSINOPHILIA-MYALGIA-SYNDROME, AFFAIRS CLINICAL-ASSESSMENT, IMPROVES EXERCISE CAPACITY, Endothelin Receptor Antagonists, Humans, Hypertension, Pulmonary, ESC/ERS Scientific Document Group, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology, 3201 Cardiovascular medicine and haematology, 3202 Clinical sciences